Sanofi's Multaq Losing Rhythm? NASDAQ In September of 2011, the European Medicines Agency recommended restricting use of Multaq following reports of two cases of serious liver injury leading to liver transplantation in patients taking the drug. Given that Multaq provides a benefit for ... |
